Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects
Abstract It is reported that pulmonary fibrosis has become one of the major long-term complications of COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global medical community, there are no treatments for COVID-induced pulmonary fibrosis. Recently, inhalable na...
Main Authors: | Qianyu Wan, Xinrui Zhang, Dongfang Zhou, Rui Xie, Yue Cai, Kehao Zhang, Xuanrong Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-01971-7 |
Similar Items
-
Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis
by: Meiling Zheng, et al.
Published: (2024-01-01) -
Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects
by: Meiling Zheng, et al.
Published: (2024-03-01) -
Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
by: Peng Lu, et al.
Published: (2022-05-01) -
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021-03-01) -
Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis
by: Mengqin Guo, et al.
Published: (2023-06-01)